Detailed assessment of axial and peripheral entheses and joints in axial spondyloarthritis and psoriatic arthritis patients treated with ixekizumab (DAPHNE): design of a 2-year phase IV trial applying whole-body MRI, MRI-based synthetic CT, and CT
BMC Rheumatol. 2025 Oct 16;9(1):120. doi: 10.1186/s41927-025-00560-5. NO ABSTRACT PMID:41102851 | DOI:10.1186/s41927-025-00560-5
